Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Other

S16 Ep38: Live Tumor Board: Precision Pathways Transforming Patient Care in Advanced NSCLC

 March 27, 2026

OncLive Podcast

In this podcast, experts Narjust Florez, MD, FASCO; David Carbone, MD, PhD; and Edward Garon, MD, MS; discuss the use of KRAS-, NRG1-, MET-, and ROS1-targeting agents to transform patient care in adva

OtherOncologyRead full story

Post navigation

Accord, Intas, and Bio-Thera File Four IPRs Against Janssen Golimumab Patents →
← Lilly puts up to $2.75bn into Insilico alliance

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com